Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions.
Diabetic macular edema (DME) and diabetic retinopathy (DR) are complications affecting about 25% of all patients with long-standing type 1 and type 2 diabetes mellitus and are a major cause of significant decrease in vision and quality of life. Age-related macular degeneration (AMD) is not uncommon, and diabetes mellitus affects the incidence and progression of AMD through altering hemodynamics, increasing oxidative stress, accumulating advanced glycation end products, etc. Recent studies suggest that DME, DR and AMD are inflammatory conditions characterized by a breakdown of the blood-retinal barrier, inflammatory processes and an increase in vascular permeability. Key factors that seem to have a dominant role in DME, DR and AMD are angiotensin II, prostaglandins and the vascular endothelial growth factor and a deficiency of anti-inflammatory bioactive lipids. The imbalance between pro- and anti-inflammatory eicosanoids and enhanced production of pro-angiogenic factors may initiate the onset and progression of DME, DR and AMD. This implies that bioactive lipids that possess anti-inflammatory actions and suppress the production of angiogenic factors could be employed in the prevention and management of DME, DR and AMD.
UND Life Sciences, USA.
Undurti N
UN
Das
diabetic retinopathy; inflammation; lipoxins; polyunsaturated fatty acids; vascular endothelial growth factor
PLoS One. 2013 Jun 24;8(6):e67120
23826208
Retina. 2014 Sep;34(9):1811-8
24801651
J Pineal Res. 2002 Jan;32(1):26-33
11841597
J Cardiovasc Transl Res. 2013 Apr;6(2):287-93
22993129
Invest Ophthalmol Vis Sci. 2012 Dec 03;53(13):7943-9
23139282
J Assoc Physicians India. 1998 Jul;46(7):630-4
12152850
Acta Obstet Gynecol Scand. 2004 Dec;83(12):1119-23
15548142
Cell Immunol. 2004 Apr;228(2):99-109
15219461
Biochem Biophys Res Commun. 2004 Oct 15;323(2):630-5
15369797
Invest Ophthalmol Vis Sci. 2012 Aug 27;53(9):5906-11
22871833
Prostaglandins Leukot Essent Fatty Acids. 1995 Jun;52(6):387-91
7644560
Prostaglandins Leukot Essent Fatty Acids. 2005 May;72 (5):301-25
15850712
Diabetologia. 1986 Aug;29(8):471-4
3019811
Lancet. 1964 Jul 4;2(7349):17-8
14149196
Invest Ophthalmol Vis Sci. 2013 Mar 01;54(3):2225-37
23462752
Neurochem Res. 2012 Aug;37(8):1690-6
22552474
Cardiovasc Diabetol. 2008 Mar 20;7:6
18355413
Rev Recent Clin Trials. 2012 Feb;7(1):71-80
21864248
Arthritis Rheum. 1995 Jun;38(6):768-76
7779119
J Cardiovasc Pharmacol. 2013 Sep;62(3):285-97
23676336
Br J Ophthalmol. 2002 Apr;86(4):363-5
11914197
Kidney Int. 2005 Jul;68(1):35-46
15954894
Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):6026-34
21447688
Surgery. 2003 Aug;134(2):329-35
12947337
Nat Med. 2007 Jul;13(7):868-73
17589522
Middle East Afr J Ophthalmol. 2012 Jan;19(1):52-9
22346115
Anesth Analg. 2007 Feb;104(2):369-77
17242094
Nutrition. 2003 Mar;19(3):213-28
12620523
J Biol Chem. 1994 Aug 26;269(34):21786-92
8063822
J Immunol. 2003 Jan 1;170(1):139-46
12496393
Eur J Ophthalmol. 2011;21 Suppl 6:S10-9
23264324
Fundam Clin Pharmacol. 2003 Jun;17(3):363-72
12803576
Prostaglandins Leukot Essent Fatty Acids. 1997 Mar;56(3):193-8
9089797
Prostaglandins Leukot Essent Fatty Acids. 1991 Aug;43(4):251-5
1658811
Arch Med Sci. 2013 Dec 30;9(6):1107-13
24482658
Ophthalmology. 2003 Sep;110(9):1690-6
13129863
Br J Ophthalmol. 1985 Apr;69(4):275-9
3857940
Ophthalmology. 2006 Nov;113(11):2002.e1-12
17027972
Arch Med Sci. 2014 Dec 22;10(6):1167-74
25624855
Prostaglandins Leukot Essent Fatty Acids. 2001 Jul;65(1):37-40
11487306
Cytokine. 2013 Jun;62(3):369-81
23601964
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6530-5
23553837
J Hum Nutr Diet. 2014 Oct;27(5):468-78
24138546
FASEB J. 2004 Sep;18(12):1450-2
15231732
Curr Pharm Biotechnol. 2011 Mar 1;12(3):396-405
20939802
J Biol Chem. 2003 Nov 7;278(45):45021-6
12944390
Clin Biochem. 2013 Jan;46(1-2):109-14
23103709
J Biochem Toxicol. 1994 Aug;9(4):181-90
7853352
Asia Pac J Clin Nutr. 2012;21(3):394-9
22705429
Expert Opin Investig Drugs. 2013 Jul;22(7):803-12
23627650
Histol Histopathol. 1997 Jan;12(1):99-109
9046048
J Nutr. 2007 Mar;137(3):641-6
17311953
Am J Physiol Gastrointest Liver Physiol. 2011 Sep;301(3):G487-97
21659618
Lipids. 2002 Nov;37(11):1047-52
12558054
J Exp Med. 2004 Jul 5;200(1):69-78
15238606
Invest Ophthalmol Vis Sci. 2013 Aug 13;54(8):5471-80
23847308
Thromb Haemost. 2007 Jan;97(1):88-98
17200775
Am J Ophthalmol. 2003 Mar;135(3):321-7
12614749
J Clin Invest. 1994 Jun;93(6):2490-6
8200985
Med Sci Monit. 2010 Sep;16(9):LE13-4
20802423
Nutrition. 2013 Jan;29(1):1-7
22677359
PLoS One. 2010 Sep 13;5(9):e12699
20856927
Free Radic Res Commun. 1993;19(1):59-66
8225035
Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:49-54
15962098
J Cardiovasc Pharmacol Ther. 2013 May;18(3):217-21
23524841
Carcinogenesis. 2004 Dec;25(12):2303-10
15358633
Ophthalmic Res. 1990;22(1):3-11
2111530
Prostaglandins Leukot Essent Fatty Acids. 2001 Jan;64(1):37-52
11161584
Nat Commun. 2015 Mar 04;6:6228
25736573
Diabetes Res Clin Pract. 2013 Apr;100(1):e11-3
23391744
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1595-9
10845877
Diabetes Care. 1986 Jan-Feb;9(1):104
3512202
Eur J Pharmacol. 1995 Dec 20;287(3):233-8
8991795
J Biol Chem. 2001 Sep 28;276(39):36059-62
11451964
FASEB J. 2007 Jul;21(9):2257-66
17384141
Adv Exp Med Biol. 2013;783:103-20
23468106
Clin Ophthalmol. 2008 Jun;2(2):369-75
19668728
FEBS Lett. 2005 Dec 19;579(30):6821-6
16325814
Prostaglandins Leukot Essent Fatty Acids. 2013 Mar;88(3):201-10
23295193
J Pathol. 2009 Dec;219(4):446-54
19768732
J Ophthalmol. 2012;2012:279037
22132315
Nutrition. 2001 Nov-Dec;17(11-12):953-66
11744348
Br J Pharmacol. 2003 Aug;139(7):1351-9
12890715
J Neurotrauma. 2004 Oct;21(10):1457-67
15672635
Prog Brain Res. 2009;175:253-67
19660661
J Nephrol. 2007 Jul-Aug;20(4):444-52
17879211
Arch Ophthalmol. 2005 Jun;123(6):774-82
15955978
J Neurotrauma. 2007 Jul;24(7):1119-31
17610352
J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):344-8
20938039
Prostaglandins Leukot Essent Fatty Acids. 2012 Jan-Feb;86(1-2):3-11
22014542
Diabetes. 2001 Jul;50(7):1636-42
11423486
Doc Ophthalmol. 2001 Jul;103(1):27-34
11678158
Lipids Health Dis. 2011 May 15;10:76
21569625
Med Sci Monit. 2012 Jan;18(1):LE1-2
22207123
Klin Monbl Augenheilkd. 2012 Dec;229(12):1204-8
22996633
Prostaglandins Other Lipid Mediat. 2006 Sep;80(3-4):123-35
16939877
Crit Rev Food Sci Nutr. 2014;54(1):1-16
24188230
Am J Ophthalmol. 2012 Jul;154(1):6-12
22709833
Mol Cancer Ther. 2010 Aug;9(8):2164-74
20682645
Diabetes. 2006 Apr;55(4):924-8
16567512
Am J Pathol. 2001 Jan;158(1):147-52
11141487
J Cell Physiol. 2003 May;195(2):210-9
12652648
Nutrition. 2003 Feb;19(2):93-114
12591540
Prostaglandins Leukot Essent Fatty Acids. 2006 Jan;74(1):39-60
16297610
Nutr Res. 2013 Oct;33(10):849-58
24074743
Acta Ophthalmol. 2011 May;89(3):203-7
21044274
Mediators Inflamm. 2013;2013:231351
23956501
Invest Ophthalmol Vis Sci. 2012 Dec 19;53(13):8472-80
23150618
EMBO Mol Med. 2015 Jan 20;7(2):211-26
25604058
PLoS One. 2013;8(1):e55177
23383097
Lancet. 2013 Oct 12;382(9900):1258-67
23870813
J Assoc Physicians India. 2006 Feb;54:133-42
16715619
Prostaglandins Leukot Essent Fatty Acids. 1994 Sep;51(3):207-13
7824535
Nutrition. 2001 Feb;17(2):126-51
11240341
Am J Clin Nutr. 2015 Apr;101(4):879-88
25833984
Nat Med. 2002 Mar;8(3):240-6
11875494
J Immunol. 2011 Aug 15;187(4):1957-69
21724996
Postepy Hig Med Dosw (Online). 2014 Jan 23;68:57-65
24491896
Diabetes. 2011 Mar;60(3):876-83
21307078
Lipids Health Dis. 2008 Oct 15;7:37
18922179
Immunol Lett. 2012 Sep;147(1-2):29-33
22698681
Med Hypotheses. 2013 Dec;81(6):1135-6
24225122
Kidney Int. 1994 Aug;46(2):341-9
7967345
Invest Ophthalmol Vis Sci. 1998 Oct;39(11):2190-4
9761301
Surv Ophthalmol. 2004 Sep-Oct;49(5):470-90
15325193
Nat Med. 1995 Oct;1(10):1024-8
7489357
JAMA Ophthalmol. 2014 Apr 1;132(4):446-55
24481424
Biochim Biophys Acta. 2013 Mar;1830(3):2649-58
23274526
Infect Immun. 2011 Apr;79(4):1489-97
21263017
Pulm Pharmacol Ther. 2011 Aug;24(4):434-41
21501693
PLoS One. 2014 Feb 19;9(2):e88201
24586307
Am J Physiol Cell Physiol. 2005 Sep;289(3):C557-63
15901601
Cardiovasc Res. 2009 Jul 1;83(1):123-30
19377066
J Leukoc Biol. 2004 Sep;76(3):719-26
15240748
J Urol. 2000 Sep;164(3 Pt 1):820-5
10953162
Lipids Health Dis. 2012 Sep 04;11:109
22943296
Nutrition. 2013 Oct;29(10):1175-85
23911220
Acta Ophthalmol. 2014 Nov;92(7):675-81
24506800
Arch Med Res. 2013 Oct;44(7):514-20
24120388
Sci Transl Med. 2011 Feb 9;3(69):69ra12
21307302
Acta Ophthalmol. 2015 Sep;93(6):533-8
25683020
Nat Med. 2004 Oct;10(10):1095-103
15378055
FASEB J. 2012 Mar;26(3):1100-9
22131271
Lipids Health Dis. 2012 Jul 10;11:90
22781401
Exp Cell Res. 1999 Mar 15;247(2):495-504
10066377
Prog Retin Eye Res. 2013 May;34:19-48
23416119
Am J Ophthalmol. 2002 Jan;133(1):70-7
11755841
Nat Rev Immunol. 2008 May;8(5):349-61
18437155
J Immunol. 2002 Mar 1;168(5):2255-63
11859113
Graefes Arch Clin Exp Ophthalmol. 1987;225(1):70-6
2436980
Am J Physiol. 1998 Oct;275(4 Pt 2):H1462-72
9746498
PLoS One. 2013;8(2):e57254
23437353
J Inflamm Res. 2010;3:143-70
22096364
Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R735-41
15371279
Mucosal Immunol. 2010 May;3(3):270-9
20130564
Invest Ophthalmol Vis Sci. 2014 Apr 09;55(4):2290-6
24398091
Indian J Ophthalmol. 2010 Sep-Oct;58(5):375-9
20689190
Am J Pathol. 1997 Sep;151(3):707-14
9284819
Clin Exp Metastasis. 1999;17(8):687-94
10919714
Curr Med Chem. 2013;20(26):3241-50
23745549
Int J Cancer. 2009 Apr 1;124(7):1545-51
19089921
Circulation. 2006 Aug 29;114(9):929-35
16908763
Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1153-8
10752954
Am J Ophthalmol. 2002 Apr;133(4):537-43
11931788
Int J Inflam. 2013;2013:348092
23762772
Inflammation. 2013 Apr;36(2):468-75
23114480
FASEB J. 2009 Nov;23(11):3947-56
19584301
Can J Diabetes. 2013 Dec;37(6):401-7
24321721
Jpn J Med. 1985 Aug;24(3):231-5
3840849
Lipids Health Dis. 2014 Feb 08;13:29
24507240